Skip to content
HowShorted

TENAX THERAPEUTICS, INC. short interest in 2025

In 2025, TENAX THERAPEUTICS, INC.'s disclosed short interest ran from 6.54% of shares outstanding on 15 Jan 2025 to 8.51% on 15 Dec 2025, a change of +1.97 percentage points. The year's high was 16.71% on 31 Oct 2025 and its low 6.04% on 15 Sep 2025, averaging 9.35% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 39.25 days on 15 Jul 2025. Full history: TENAX THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TENAX THERAPEUTICS, INC. in 2025

2025 in figures

Start of year
6.54% (15 Jan 2025)
End of year
8.51% (15 Dec 2025)
Change
+1.97 pp
High
16.71% (31 Oct 2025)
Low
6.04% (15 Sep 2025)
Average
9.35%
Highest days to cover
39.25 (15 Jul 2025)
SEC filings marked
8

Every report in 2025

TENAX THERAPEUTICS, INC. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20256.54%6.66
31 Jan 20256.37%9.18
14 Feb 202512.31%6.10
28 Feb 202511.20%13.80
14 Mar 202510.96%6.26
31 Mar 20259.18%14.0710-K filed, results (8-K)
15 Apr 20258.47%19.54
30 Apr 20257.77%20.57
15 May 20257.48%30.2610-Q filed, results (8-K)
30 May 20257.49%31.15
13 Jun 20257.51%19.15
30 Jun 20258.12%4.69
15 Jul 20258.11%39.25
31 Jul 20258.06%9.83
15 Aug 20257.16%26.0010-Q filed, results (8-K)
29 Aug 20256.53%16.38
15 Sep 20256.04%5.50
30 Sep 202512.14%3.40
15 Oct 202516.53%7.11
31 Oct 202516.71%8.81
14 Nov 202512.14%19.3910-Q filed, results (8-K)
28 Nov 20259.62%4.50
15 Dec 20258.51%2.84

See also: TENAX THERAPEUTICS, INC.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.